Patents by Inventor Julio Boza
Julio Boza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8557560Abstract: The present invention relates to a novel approach to prevent or treat mastitis both in humans and animals through the use of mammal milk-derived microorganisms obtained from healthy hosts of the homologous species; to those new probiotic microorganisms obtained from milk able to reduce infectious mastitis and the method of screening used for their obtaining; to the use of these probiotic bacteria for the prophylaxis or treatment against mastitis and other diseases; and finally, to compositions comprising these compounds.Type: GrantFiled: June 2, 2008Date of Patent: October 15, 2013Assignee: Puleva Biotech, S.A.Inventors: Rocio Martín Jiménez, Mónica Olivares Martín, Esther Antonia Jiménez Quintana, Maria Luisa Marín Martínez, Saleta Sierra Ávila, Antonio Maldonado Barragán, Virginia Martín Merino, Francesc Blanch Martell, Celina Torre Lloveras, Federico Lara Villoslada, Rebeca Arroyo Rodríguez, Julio Boza Puerta, Jesús Jiménez López, Leónides Fernández Álvarez, Odón Julían Sobrino Abuja, Jordi Xaus Pei, Juan Miguel Rodríguez Gómez, Susana Delgado Palacio
-
Patent number: 8383680Abstract: A method is provided for the prevention and treatment of patients having impaired gastro-intestinal tract function. The method comprises the steps of administering to a patient requiring same free amino acids including about 9.0% to about 17.0% glutamic acid.Type: GrantFiled: October 18, 2011Date of Patent: February 26, 2013Assignee: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Publication number: 20120128815Abstract: A performance enhancing sports drink is described. The drink, which is useful before, during, and after exercise, is specially developed to reduce lactate production, reduce perceived exhaustion, reduce muscle soreness (both actual muscle damage and perceived soreness), and reduce net fluid loss observed with exercise.Type: ApplicationFiled: November 18, 2011Publication date: May 24, 2012Applicant: The Coca-Cola CompanyInventors: Sylvia P. Poulos, Julio Boza, Robert O. Scott
-
Patent number: 8178487Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.Type: GrantFiled: November 24, 2008Date of Patent: May 15, 2012Assignee: Nestec S.A.Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
-
Publication number: 20120035234Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: October 18, 2011Publication date: February 9, 2012Applicant: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
-
Patent number: 8067471Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.Type: GrantFiled: April 28, 2006Date of Patent: November 29, 2011Assignee: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
-
Publication number: 20100266550Abstract: The present invention relates to a novel approach to prevent or treat mastitis both in humans and animals through the use of mammal milk-derived microorganisms obtained from healthy hosts of the homologous species; to those new probiotic microorganisms obtained from milk able to reduce infectious mastitis and the method of screening used for their obtaining; to the use of these probiotic bacteria for the prophylaxis or treatment against mastitis and other diseases; and finally, to compositions comprising these compounds.Type: ApplicationFiled: June 2, 2008Publication date: October 21, 2010Applicant: PULEVA BIOTECH, S.A.Inventors: Rocio Martín Jiménez, Monica Olivares Martín, Esther Antonia Jiménez Quintana, Maria Luisa Marín Martínez, Saleta Sierra Ávila, Antonio Maldonado Barragán, Virginia Martín Merino, Francesc Blanch Martell, Celina Torre Lloveras, Federico Villoslada, Reebeca Arroyo Rodríguez, Julio Boza Puerta, Jesús Jiménez López, Leónides Fernández Álvarez, Odón Julían Sobrino Abuja, Jordi Xaus Pei, Juan Miguel Rodríguez Gómez, Susana Delgado Palacio
-
Patent number: 7794744Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.Type: GrantFiled: April 3, 2001Date of Patent: September 14, 2010Assignee: Nestec S.A.Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-André Finot, Véronique Jaussan, Claudia Roessle, Thomas Schweizer
-
Publication number: 20090075862Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.Type: ApplicationFiled: November 24, 2008Publication date: March 19, 2009Applicant: NESTEC S.A.Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
-
Patent number: 7468270Abstract: The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pathogenic strains which are able to be transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas. The invention also provides new Lactobacillus strains, which are: CECT5711 (Lactobacillus coryniformis), CECT5713 (Lactobacillus salivarius subsp. salivarius), CECT5714: (Lactobacillus gasseri, formerly L. acidophilus), CETC5715: (Lactobacillus gasseri), and CECT5716: (Lactobacillus fermentum); and refers to their use for the prophylaxis or treatment against digestive, infective, neuro-degenerative and immune related diseases such as allergies or inflammatory diseases.Type: GrantFiled: December 28, 2004Date of Patent: December 23, 2008Assignee: Puleva Biotech, S.A.Inventors: Jordi Xaus Pei, Rocío Martin Jiménez, Juan Miguel Rodríguez Gómez, Julio Boza Puerta, Jesús Jiménez López
-
Publication number: 20080132454Abstract: The present invention refers to novel antihypertensive peptides which may be used as active ingredients in pharmaceutical preparations, dietary supplements, or as food ingredients.Type: ApplicationFiled: February 23, 2005Publication date: June 5, 2008Inventors: Arjian Geerlings, Fernando Hidalgo Hidalgo Zarco, Julio Boza Puerta, Jesus Jimenez Lopez
-
Publication number: 20060247312Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. A method of production of the composition; use of the composition in the manufacture of a medicament; and a method of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: April 28, 2006Publication date: November 2, 2006Applicant: NESTEC S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Patent number: 7098246Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.Type: GrantFiled: April 3, 2003Date of Patent: August 29, 2006Assignee: Puleva Biotech, S.A.Inventors: Arjan Geelings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesús Jimenez Lopez
-
Publication number: 20040096478Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. A method of production of the composition; use of the composition in the manufacture of a medicament; and a method of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: January 2, 2003Publication date: May 20, 2004Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Publication number: 20040057943Abstract: The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pathogenic strains which are able to be transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas. The invention also provides new Lactobacillus strains, which are: CECT5711 (Lactobacillus coryniformis), CECT5713 (Lactobacillus salivarius subsp. salivarius), CECT5714: (Lactobacillus gasseri, formerly L. acidophilus), CETC5715: (Lactobacillus gasseri), and CECT5716: (Lactobacillus fermentum); and refers to their use for the prophylaxis or treatment against digestive, infective, neuro-degenerative and immune related diseases such as allergies or inflammatory diseases.Type: ApplicationFiled: June 26, 2003Publication date: March 25, 2004Inventors: Jordi Xaus Pey, Rocio Martin Jimenez, Juan Miguel Rodriguez Gomez, Julio Boza Puerta, Jesus Jimenez Lopez
-
Publication number: 20030236202Abstract: The invention relates to the use of phenolic compounds and derivatives thereof for protection against neurodegenerative diseases, to compositions comprising these compounds, and to some novel phenolic compounds.Type: ApplicationFiled: April 3, 2003Publication date: December 25, 2003Inventors: Arjan Geelings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesus Jimenez Lopez
-
Publication number: 20030225160Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.Type: ApplicationFiled: April 3, 2003Publication date: December 4, 2003Inventors: Arjan Geerlings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesus Jimenez Lopez
-
Publication number: 20030161863Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.Type: ApplicationFiled: February 21, 2003Publication date: August 28, 2003Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-Andre Finot, Veronique Jaussan, Claudia Roessle, Thomas Schweizer
-
Patent number: 5849335Abstract: A nutritional composition for providing glutamine to a human or animal. The protein source of the composition includes carob protein which is rich in glutamine. A source of Met may also be included. The composition may be used in the treatment of stressed patients; for example those patients who are critically ill, suffering from sepsis, injury, burns, or inflammation, or who are recovering from surgery. Further, the composition may be used to raise plasma glutamine levels; for example in athletes after intense exercise.Type: GrantFiled: June 2, 1997Date of Patent: December 15, 1998Assignee: Nestec S.A.Inventors: Olivier Ballevre, Krishna Anantharaman, Julio Boza, Clara-Lucia Garcia-Rodenas